Streetbeat News

Products Services

CTNM

Contineum Therapeutics, Inc (NASDAQ:CTNM) is set to begin trading on NASDAQ on April 05, with its IPO priced between $16.00 and $18.00 per share. The company, a clinical stage biopharmaceutical firm, focuses on developing therapies for NI&I indications with high unmet need. An insider lock-up period is set for 180 days, ending on October 02, 2024.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 3:00 pm

F

Ford Motor Co (NYSE:F) is delaying the launch of its new three-row electric vehicles in Oakville, Ontario, to 2027 from 2025, citing the need for further market development and advancements in battery technology. The company is also progressing with its Tennessee Electric Vehicle Center for a next-generation electric truck expected in 2026 and plans to begin tool installation at the Ohio Assembly Plant in spring 2025. Ford aims to offer hybrid powertrains across its entire Ford Blue lineup in North America by the end of the decade. In Q1 of 2024, Ford's electric vehicle sales increased by 86%, and hybrid sales rose by 42% year-over-year. The company is working with Unifor to address the impact of the launch delay on its workforce at Oakville. Ford's shares rose by 1.72% to $13.89.

Portfolio Pulse from Shivani Kumaresan

April 04, 2024 | 2:56 pm

ETHUSD

XRPUSD

Ripple announced the launch of a U.S. dollar-pegged stablecoin on the XRP Ledger and Ethereum, aiming to compete with Tether and Circle in the $150 billion stablecoin market. The stablecoin is backed by U.S. dollar deposits, short-term U.S. government treasuries, and cash equivalents, with plans for third-party audits and monthly attestations for transparency. This move is seen as a strategic step for Ripple and is expected to enhance liquidity and opportunities for the XRP Ledger community.

Portfolio Pulse from Murtuza Merchant

April 04, 2024 | 2:54 pm

ADCT

ADC Therapeutics' shares are trading higher following the announcement of the completion of dose escalation in the LOTIS-7 Phase 1b clinical trial. This trial evaluates ZYNLONTA in combination with glofitamab or mosunetuzumab for treating heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 2:50 pm

TSLA

Tesla, Inc. is planning to import cars made at its Giga Berlin factory to India, following the country's relaxation of import duties. This move comes as Tesla aims to capitalize on the reduced tax rate for imported cars costing $35,000 or more, which now stands at 15% compared to the previous 70%-100%. The company is also reducing sourcing from China and looking to increase imports from India, with plans to invest in a charging network and a $2 billion manufacturing plant in India.

Portfolio Pulse from Shanthi Rexaline

April 04, 2024 | 2:46 pm

IBKR

Interactive Brokers Group Inc (NASDAQ:IBKR) has launched a new desktop trading application for Windows and Mac, aiming to redefine trading technology expectations. The platform, designed for serious investors, supports trading in multiple asset classes worldwide and offers features like various order types, options visualization, and technical analysis tools. The company emphasizes its competitive advantages in product breadth, cost, technology, and financial strength. Additionally, Interactive Brokers is expanding its offerings with retirement planning tools and an HTML-based client portal for advisors.

Portfolio Pulse from Renato Capelj

April 04, 2024 | 2:44 pm

FBTC

GBTC

IBIT

James Wo, CEO of Digital Finance Group, predicts a high likelihood of ETH Spot ETFs approval, citing SEC's positive stance and previous approvals of ETH Futures ETFs. The anticipation mirrors the success of Bitcoin ETFs like GBTC, IBIT, and FBTC. Wo also discusses the strong Q1 2024 performance of the cryptocurrency market, potential in NFTs, and the importance of addressing security in blockchain and DeFi for future growth.

Portfolio Pulse from Surbhi Jain

April 04, 2024 | 2:41 pm

EFTR

MRK

eFFECTOR Therapeutics Inc (EFTR) announced disappointing results from the Phase 2 KICKSTART trial of tomivosertib in combination with Merck & Co Inc's (MRK) Keytruda for non-small cell lung cancer, failing to meet the primary endpoint. The company will discontinue the development of tomivosertib for this indication but plans to focus on developing Zotatifin for breast cancer and continue a trial of tomivosertib in AML. EFTR shares dropped 78.1% to $3.6.

Portfolio Pulse from Vandana Singh

April 04, 2024 | 2:38 pm

CVX

Chevron Corp (NYSE:CVX) has invested $45 million in Series A financing in ION Clean Energy, a Boulder, Colorado-based technology company specializing in carbon capture technology. This investment aims to support the growth and commercial rollout of ION's ICE-31 liquid amine carbon capture technology, targeting hard-to-abate emissions. The collaboration is part of Chevron's strategy to expand its technology portfolio and address emissions from industries with high-volume but low-concentration CO2 emissions, marking a significant step towards a lower carbon future.

Portfolio Pulse from Akanksha Bakshi

April 04, 2024 | 2:36 pm

RIOT

Riot Blockchain, Inc. (RIOT) shares are experiencing an uptick following the announcement of their March Bitcoin production figures, which totaled 425 Bitcoins.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 2:30 pm